| Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy X Chen, S Yang, S Li, Y Qu, HY Wang, J Liu, ZS Dunn, GE Cinay, ... Molecular Therapy-Oncolytics 21, 144-157, 2021 | 38 | 2021 |
| Adenosine deaminase 1 overexpression enhances the antitumor efficacy of chimeric antigen receptor-engineered T cells Y Qu, ZS Dunn, X Chen, M MacMullan, G Cinay, H Wang, J Liu, F Hu, ... Human Gene Therapy 33 (5-6), 223-236, 2022 | 25 | 2022 |
| Antitumor activity of T cells expressing a novel anti-folate receptor alpha (FOLR1) costimulatory antigen receptor (CoStAR) in a human xenograft murine solid tumor model and … OR Moon, Y Qu, MG King, M Mojadidi, C Chauvin-Fleurence, C Yarka, ... Journal of Clinical Oncology 40 (16_suppl), 2535-2535, 2022 | 3 | 2022 |
| Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor … M Kalaitsidou, OR Moon, M Sykorova, L Bao, Y Qu, S Sukumaran, ... Frontiers in Immunology 14, 1256491, 2023 | 2 | 2023 |
| Engineering CAR-expressing natural killer cells with cytokine signaling and synthetic switch for an off-the-shelf cell-based cancer immunotherapy Y Qu, E Siegler, C Cheng, J Liu, G Cinay, N Bagrodia, P Wang MRS Communications 9 (2), 433-440, 2019 | 2 | 2019 |
| Phospho-proteomic analysis of CAR-T cell signaling following activation by antigen-presenting cancer cells MA MacMullan, ZS Dunn, Y Qu, P Wang, NA Graham bioRxiv, 2022.02. 24.481820, 2022 | 1 | 2022 |
| Secretion of 4-1BB Ligand Crosslinked to PD-1 Checkpoint Inhibitor Potentiates Chimeric Antigen Receptor T Cell Solid Tumor Efficacy ZS Dunn, Y Qu, M MacMullan, X Chen, G Cinay, P Wang Human Gene Therapy 34 (21-22), 1145-1161, 2023 | | 2023 |
| Secretion of 4-1BB ligand crosslinked to PD-1 checkpoint inhibitor potentiates CAR T cell solid tumor efficacy. Z Dunn, Y Qu, M MacMullan, X Chen, G Cinay, P Wang Human Gene Therapy, 2023 | | 2023 |
| 111 Armored CAR T cells secreting 4–1BB ligand crosslinked to PD-1 checkpoint inhibitor for enhanced solid tumor efficacy Z Dunn, Y Qu, M MacMullan, X Chen, G Cinay, P Wang Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
